Medication-Assisted Treatment Options: 5 Powerful Ways to Recovery
Why Medication-Assisted Treatment Options Are Changing Lives Every Day
Medication-assisted treatment options combine FDA-approved medications with counseling to treat substance use disorders. Here are the main options available:
For Opioid Use Disorder:
- Buprenorphine/Suboxone® – Can be prescribed in doctor’s offices, low overdose risk
- Methadone – Gold standard treatment, requires daily clinic visits
- Naltrexone – Blocks opioid effects, available as monthly injection
For Alcohol Use Disorder:
- Acamprosate – Reduces cravings and withdrawal symptoms
- Disulfiram – Creates unpleasant reaction when alcohol is consumed
- Naltrexone – Blocks euphoric effects of alcohol
Over 6.1 million Americans struggle with opioid use disorder, yet only 11% receive FDA-approved medication for their condition. Research shows that medication-assisted treatment increases patient survival rates, boosts treatment retention, and reduces criminal activity.
Recovery isn’t one-size-fits-all. Some people thrive with daily structure at a methadone clinic. Others need the flexibility of home-based buprenorphine treatment. Still others benefit from monthly naltrexone injections.
These aren’t “trading one drug for another” – they’re evidence-based medicines that normalize brain chemistry and save lives.
I’m Dr. Chad Elkin, a board-certified addiction medicine physician and founder of National Addiction Specialists, where I’ve helped thousands of patients steer medication-assisted treatment options through our telehealth platform.
Quick medication-assisted treatment options definitions:
Understanding Medication-Assisted Treatment (MAT): Science, Survival, and Success
Addiction isn’t a character flaw – it’s a chronic medical condition that rewires your brain chemistry. When someone has diabetes, we don’t tell them to “just try harder” to make insulin. We give them the medicine they need. The same logic applies to substance use disorders.
Scientific research on MAT outcomes shows that medication-assisted treatment options work by fixing the chemical imbalances addiction creates in your brain. These medications don’t make you “high” when used properly – they help restore normal brain function.
MAT reduces emergency room visits by 51% among people with opioid use disorder. A five-year study found that patients on buprenorphine had a 33.2% abstinence rate from heroin. MAT also helps people increase treatment retention, reduce criminal activity, find jobs, and rebuild relationships.
Think of MAT like managing any other chronic condition. Someone with high blood pressure might need medication for life. People with substance use disorders often benefit from long-term medication management too.
How Medication-Assisted Treatment Options Work in the Body
Your brain has opioid receptors – think of them as locks that opioids can open. When someone uses opioids regularly, these receptors become dependent on constant stimulation.
Partial agonists like buprenorphine work like keys that only turn halfway in the lock. They prevent withdrawal and cravings without causing euphoria. Buprenorphine has a “ceiling effect” – taking more doesn’t increase any high, reducing overdose risk.
Full agonists like methadone completely activate opioid receptors in a controlled, long-acting way. They prevent withdrawal while blocking effects of other opioids.
Antagonists like naltrexone completely block opioid receptors. If someone tries to use opioids while on naltrexone, nothing happens.
The goal is to reset your dopamine system and normalize brain function, allowing you to focus on rebuilding your life without constant cravings.
Why Counseling & Behavioral Therapies Boost MAT
While medications stabilize brain chemistry, counseling addresses emotional and behavioral patterns that fuel addiction. More info about importance of therapy shows approaches that work well with medication-assisted treatment options.
Cognitive Behavioral Therapy (CBT) helps identify triggers and develop healthy coping strategies. Contingency management rewards positive behaviors like clean drug tests. Motivational interviewing helps you find personal reasons for change.
At National Addiction Specialists, we integrate counseling into our telehealth platform because medication gets people stable, but therapy helps them build skills to thrive long-term.
Make an Appointment to Treat Addiction
Please don’t hesitate. Make an appointment today.
FDA-Approved Medication-Assisted Treatment Options
The FDA has approved several medications with proven track records for treating substance use disorders safely and effectively.
For opioid use disorder, you have three main tools: buprenorphine, methadone, and naltrexone. For alcohol use disorder, there’s acamprosate, disulfiram, and naltrexone. Scientific research on buprenorphine effectiveness confirms these medications save lives when matched correctly to each person’s situation.
Buprenorphine/Suboxone® Basics
Buprenorphine is versatile, safe, and effective for most people. More info about Suboxone explains that Suboxone combines buprenorphine with naloxone as a built-in safety feature.
What makes buprenorphine special is its ceiling effect. Unlike other opioids where taking more gives bigger effects and overdose risk, buprenorphine hits a ceiling. This makes it much safer than street drugs.
You can get buprenorphine from regular doctors through telehealth platforms like ours at National Addiction Specialists. No special clinics or daily visits required. Most insurance plans, including Medicaid, cover it well.
Methadone: The Gold Standard—But Clinic-Based
Methadone has earned its reputation as the gold standard of addiction treatment. Research shows the highest treatment retention rates and greatest reduction in illicit drug use when dosed properly (usually 80-100 mg daily or higher).
Federal regulations require methadone dispensing only through Opioid Treatment Programs (OTPs) – specialized clinics with daily visits initially. For some, this structure is helpful. For others, especially in rural areas, the clinic requirement creates barriers.
Methadone requires careful medical monitoring for heart rhythm effects and drug interactions. But the long-term data shows decades of sustained recovery and improved quality of life.
Naltrexone: Pill vs Extended-Release Injection
Naltrexone blocks opioid receptors entirely. The daily pill has poor success rates because when cravings hit, it’s easy to skip the pill. The monthly injection (Vivitrol) removes daily decision-making and has much better outcomes.
Naltrexone’s biggest challenge is the opioid-free window required before starting – you need to be completely off opioids for 7-14 days. But for those who make it through, naltrexone offers unique benefits: no physical dependence, no diversion risk, and it works for both opioid and alcohol use disorders.
Choosing Between Medication-Assisted Treatment Options: Head-to-Head Comparison
Picking the right medication-assisted treatment options doesn’t have to be overwhelming. Methadone consistently shows the highest retention rates but requires daily clinic visits. Buprenorphine offers flexibility with telehealth options and lower overdose risk. Naltrexone works for highly motivated patients seeking complete abstinence.
Timing requirements matter: Methadone can start at any stage. Buprenorphine requires moderate withdrawal symptoms first. Naltrexone demands complete abstinence for 7-14 days.
Convenience varies significantly. Buprenorphine offers the most flexibility with office-based treatment and telehealth. Methadone requires daily structure initially. Naltrexone means monthly appointments only.
Side-Effects & Safety Monitoring
Every medication has side effects, but they’re manageable and nothing compared to untreated addiction dangers.
Constipation tops the list for methadone and buprenorphine. Mild drowsiness happens initially as your body readjusts. Nausea and headaches occur sometimes during the first weeks.
Serious effects are rare but important: Respiratory depression can happen if you combine MAT with alcohol or benzodiazepines. Precipitated withdrawal occurs if buprenorphine starts too early – temporarily miserable but preventable with proper timing.
Eligibility & Personalized Selection
Medical factors influence selection. Liver problems might favor methadone over buprenorphine. Heart issues might make buprenorphine safer. Pregnancy changes everything – buprenorphine and methadone are safe during pregnancy, naltrexone isn’t.
Personal preferences matter enormously. Geographic location is crucial – our telehealth opioid treatment platform makes buprenorphine accessible in remote areas.
The beautiful thing about medication-assisted treatment options is flexibility. If one doesn’t work, we can try another. Recovery is a journey, and treatment can evolve with you.
Getting Started: Access, Induction, and Long-Term Care
Starting medication-assisted treatment options begins with comprehensive assessment. We’ll discuss your substance history, current health, and goals through telehealth or in-person visits.
During initial visits, we review medical history, current medications, and may order lab work. Medication selection becomes personal based on your lifestyle, work schedule, and support system.
Induction requires careful timing, especially with buprenorphine. You’ll need moderate withdrawal before safely starting to avoid precipitated withdrawal. We use screening tools like COWS to ensure proper timing.
Regular follow-up appointments start weekly or bi-weekly as we fine-tune dosing. Urine drug screening helps us understand treatment effectiveness and ensure safety.
Find local MAT providers can help locate services. Our telehealth platform brings treatment directly to patients throughout Tennessee and Virginia.
Barriers & Solutions in Underserved Areas
30% of rural residents live in counties without buprenorphine providers, compared to 2.2% of urban residents. Provider shortages, transportation barriers, and stigma in small communities create challenges.
Solutions are emerging: X-waiver elimination allows more doctors to prescribe buprenorphine. Telehealth expansion eliminates transportation barriers. Mobile treatment units serve some rural areas. Medicaid expansion improves coverage.
Financial Considerations & Insurance Coverage
Most insurance plans cover medication-assisted treatment options under mental health parity laws. Medicaid and Medicare generally include all FDA-approved MAT medications. Generic buprenorphine costs less than brand-name options.
At National Addiction Specialists, we accept Medicaid and Medicare and work to make treatment affordable. Our telehealth model saves transportation costs.
Make an Appointment to Treat Addiction
Please don’t hesitate. Make an appointment today.
Myth-Busting & Safety FAQs About Medication-Assisted Treatment Options
Despite decades of research, medication-assisted treatment options still face unfair criticism. Let’s set the record straight with science, not stigma.
The biggest myth? “You’re just trading one drug for another.” These are FDA-approved medications that restore normal brain chemistry without euphoria. When someone takes insulin for diabetes, we don’t say they’re “addicted to insulin.”
Another myth claims people on MAT “aren’t really sober.” True sobriety is freedom from compulsive substance use that causes harm. Taking prescribed medication as directed while living productively is absolutely sobriety.
FAQ 1: “How long will I need MAT?”
It depends entirely on you. Some patients thrive with six to twelve months. Others need years. Some choose indefinite maintenance – all perfectly valid.
Research shows longer treatment durations produce better outcomes. Patients staying on MAT for at least twelve months have significantly lower relapse rates. But everyone’s timeline differs based on response, stability, and personal goals.
FAQ 2: “Is MAT safe with other medications?”
Generally yes, but coordination is key. The most concerning interaction involves benzodiazepines – combining these with MAT significantly increases overdose risk. Alcohol is never safe to mix with MAT medications.
At National Addiction Specialists, we review all medications during every visit and coordinate with your other healthcare providers.
FAQ 3: “Will MAT show up on employment drug screens?”
Buprenorphine might show on advanced tests but typically won’t appear on standard five-panel employment screens. Methadone shows on specific tests but isn’t part of standard screening. Naltrexone typically doesn’t appear on standard screens.
There are legal protections for people in treatment programs. The Americans with Disabilities Act may protect against discrimination based on addiction treatment participation.
Make an Appointment to Treat Addiction
Please don’t hesitate. Make an appointment today.
Conclusion
After helping thousands of patients find recovery: medication-assisted treatment options aren’t just medical interventions – they’re doorways to getting your life back.
Recovery isn’t one-size-fits-all. Some patients thrive with buprenorphine’s flexibility, others with methadone’s structured support, still others with naltrexone’s blocking approach. Modern addiction medicine matches treatments to people, not the reverse.
The science is overwhelming. MAT saves lives and helps people rebuild relationships, return to work, and become the family members and community members they want to be.
At National Addiction Specialists, telehealth makes expert addiction medicine accessible in ways previously impossible. We combine medication-assisted treatment options with counseling and ongoing care because recovery involves building a life worth living.
If you’re wondering whether treatment could help, know this: seeking help is strength, not weakness. Addiction is a medical condition that responds to medical treatment.
Make an Appointment to Treat Addiction
Please don’t hesitate. Make an appointment today.
Schedule your consultation
The path to recovery starts with a single conversation. Let us help you take that first step from the comfort and privacy of your own home.
More info about Medication-Assisted Treatment
Medically Reviewed By
Medically Reviewed ByChad D. Elkin, MD, FASAM, ABIM, ABPM
Chad D. Elkin, MD, FASAM, ABIM, ABPM, is double board-certified in both Internal Medicine and Addiction Medicine and is a Fellow of the American Society of Addiction Medicine (ASAM). His professional interests focus on social determinants of health, addiction medicine, public education concerning the opioid epidemic, public speaking engagements, and addiction medicine legislative advocacy at the state and national level . He is heavily involved with ASAM with both national and state roles including activity on the Practice Management and Regulatory Affairs Committee (PMRAC), State Advocacy and Legislative Affairs Committee (SALC), and is the Legislative Chairman and President-elect for the Tennessee chapter of ASAM.
Suboxone® and Subutex® are a registered trademark of Indivior UK Limited. Any mention and reference of Suboxone® and Subutex® in this website is for informational purposes only and is not an endorsement or sponsorship by Indivior UK Limited.
